Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2015

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2015
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2015
The figures have not been audited

Attachments

Pharma Q3 Fin Result.pdf
234.3 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2015

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2015
30 Sep 2014
30 Sep 2015
30 Sep 2014
$$'000
$$'000
$$'000
$$'000
1 Revenue
524,413
502,086
1,509,162
1,495,830
2 Profit/(loss) before tax
25,337
24,945
89,005
87,726
3 Profit/(loss) for the period
19,975
15,001
68,543
57,604
4 Profit/(loss) attributable to ordinary equity holders of the parent
19,971
14,955
67,982
57,147
5 Basic earnings/(loss) per share (Subunit)
7.71
5.78
26.26
22.07
6 Proposed/Declared dividend per share (Subunit)
9.00
8.00
23.00
16.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
2.0630
2.0340

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 26 Nov 2015
Category Financial Results
Reference Number FRA-23112015-00023